Alps Advisors Inc Prothena Corp Public LTD CO Transaction History
Alps Advisors Inc
- $14.1 Billion
- Q1 2024
A detailed history of Alps Advisors Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Alps Advisors Inc holds 37,889 shares of PRTA stock, worth $764,600. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,889
Previous 36,530
3.72%
Holding current value
$764,600
Previous $1.33 Million
29.31%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding PRTA
# of Institutions
188Shares Held
45.4MCall Options Held
119KPut Options Held
144K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$234 Million8.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.2MShares$84.8 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.75MShares$75.7 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.72MShares$75 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$70.1 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $947M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...